We are closely monitoring the COVID-19 outbreak and its impact on clinical trial patient recruitment, engagement, and compliance. As the health and wellbeing of patients remains our priority, we’ve outlined key solutions clinical trial sponsors can quickly deploy to enhance compliance and ensure patients are able to continue with their clinical trial participation.
Topics: Patient Engagement, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer